Back to Journals » Biologics: Targets and Therapy » Volume 9

Letter

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

       
Total article views   HTML views PDF downloads Totals
11,042 Dovepress* 10,596+ 1,768 12,364
PubMed Central* 446 155 601
Totals 11,042 1,923 12,965
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar